| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2872475 | The Annals of Thoracic Surgery | 2014 | 9 Pages |
Abstract
We demonstrate a 19% early recurrence rate in R0 resected node-negative T1 to T2b NSCLC. The identification of unique predictors of recurrence is an important step toward defining a patient population that may benefit from adjuvant therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Armin MD, Matthew D. MD, Damien J. MD, MS, James M. MD, MSCI, Christine L. MD, MBA, Benjamin D. MD, MPH, David R. MD,